Professional Documents
Culture Documents
MEMBER OF GROUP
1.
2.
3.
4.
KUSPRATAMA
29113021
FARIEZA QORIYANA
29113020
HALIFAH HAMZAH
29113069
DYAN SAPTURA
291130088
5. WILMAN NOVIYANDI29113054
YP 49
(Kenya Medical Supplies Agency) KEMSA is a body specifically established by the Kenyan
government to manage the circulation of drugs in the country. KEMSA is a state-owned
company that was given full authority to regulate the management of medicines in the
country of Kenya starting from the procurement, storage and distribution to the consumer.
The Kenya Medical Supplies Agency (KEMSA) is a specialized logistics providers for
medical Government Ministries of Medical Services / Public Health-supported health
facilities and Programmes in Kenya. KEMSA was established as a state corporation under
Cap 446, through the Kenya Medical Supplies Agency Order, 2000 (Legal Notice 17 of 11
February 2000) .It plays the role of procuring, storing and distributing commodities for the
public health sector. The role of KEMSA in healthcare industries is for:
1. Developing and operating a viable commercial service for the procurement and sale of
drugs and other medical supplies,
2. Providing a secure source of drugs and other medical supplies for public health
institutions,
3. Advising the Health Management Boards and the general public on matters related to
the procurement, cost effectiveness and rational use of drugs and other medical
supplies.
Along with the extension of the scope of activities undertaken by KEMSA, which is
responsible for distributing all drugs in Kenya region then comes the problem during the
process of implementation. Problems faced today by KEMSA is still not able to meet the
market demand for the drugs it supplies. KEMSA during the process of undergoing the
medicines supply chain, only able to meet the needs of the market as much as 21% of the
total demand in all regions of Kenya. It is definitely going to make a vacuum in the supply of
medication at hospitals and pharmacies are ordered directly from the warehouse inventories
of KEMSA
Seeing the problems occurred, KEMSA currently working with the team from the World
Bank to work together finding solutions to problems that are estimated occured in the supply
chain process that is implemented by KEMSA in distributing the medicine. As we have seen
that the problem of drug supply can not meet the market demand, it will have an impact on
the quality of health of the population in the country of Kenya where many residents who
need medication when it turns out they can not have it on when needed. It will also have an
impact on the public perception of systematic credibility and concern current government
goes. Things like this certainly can not be left continously, so that the handling of this issue
must be addressed seriously and become a top priority.
B. Case Diagnosis
In the process of conducting its business activities, KEMSA as the main actors in the
distribution of drugs throughout the region Kenya has a problem that has a significant impact
1
on the sustainability of its business, which is not able to meet the needs of the market over the
circulation of drugs. KEMSA is only able to meet the needs of as many as one-fifth of the
total market demand in all regions of Kenya. This of course has the financial and political
impact as the state-owned company. The financial impact is the loss of the opportunity to
gain more sales bazaar and political impact is the decline in the credibility of the people of
Kenya on his government's performance.
KEMSA in collaboration with the World Bank team to find solutions to problems that arise at
this time. The weakness of the key points related to the supply chain process that is run by
KEMSA in the operations which resulted in case this problem arises. The weak points in the
supply chain include:
1. authorization process that is executed by supply chain KEMSA still centralized,
meaning that there is only one distribution center (DC) located in Nairobi, in charge
of organizing the flow of medicine distribution throughout the territory of Kenya.
2. Storage warehouses owned KEMSA drugs outside of Nairobi is used only to store
goods inventory turnover process is slow.
3. It took a long time to deliver drugs from warehouses up to the outskirts of large cities
because the access road is not as good as the urban area, especially during the rainy
season lasts
4. Transportation costs take a lot of proportion compared to most other operational costs.
Nearly 50% of the operational costs incurred by KEMSA used to finance the delivery
process of medicine to the consumers
C. Case Question
1. What are the main challenge of Kenya Healthcare Network System ?
The main challenges currently being faced by KEMSA is going to meet all
the needs of consumers of drugs-presumably the circulation approximately
90% of the total market demand in all regions of Kenya in urban, rural,
coastal areas and even border in all regions of Kenya. Until now KEMSA
can only meet 21% of the total market demand in all regions of Kenya, so
it means in every years the medicine in a several regions will be scare and
stocked out due of lack of the medicine inventory both in hospital and
pharmacies.
The other challenges are to overcome transportation costs were deemed
too big which reached 40% - 50% of the total costs incurred by KEMSA in
running their business. Another solution needs to be done to reduce this
massive transportation cost compared to the other expenses. The other is
how to distributed medical equipment also medicine to big city or rural areas so can
create distribution system more efficiently than before.
2. What the approach taken to solve the problem ?
Although each solution can be made inserted into a simulation, but the results of these
simulations are not pure true, because there are many other criteria that may affect the
results of the field or in fact events beyond the control of the company. (Out of control
dimension)
(Figure 3 : Supply Chain Guru Interface)